Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07126587 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Healthy Living Anson Study

Study acronym: HLA
StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial completed Final enrollment: 44 participants (planned 120) · Primary completion date changed from estimate of Mar 30, 2028 to Aug 28, 2026 · Eligibility criteria expanded, about 9 words · 2 more Show 5 more changesShow less
    • Final enrollment: 44 participants (planned 120)
    • Primary completion date changed from estimate of Mar 30, 2028 to Aug 28, 2026
    • Eligibility criteria expanded, about 9 words
    • Secondary endpoints: details revised at 3 of 3 entries
    • Site details revised
  2. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Sep 1, 2025 to Sep 24, 2025 · Site details revisedv2 Show 2 more changesShow less
    • Start date changed from estimate of Sep 1, 2025 to Sep 24, 2025
    • Site details revised
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
University of North Carolina, Chapel Hill
251 trials monitored
See 19 trials at risk
Diabetes
4,286 trials monitored
See 187 trials at risk
Obesity
3,560 trials monitored
See 142 trials at risk
Heart Disease
2,136 trials monitored
See 109 trials at risk
and 2 more diseases
The goal of this randomized delayed control intervention research study is to see if participants who receive education and healthy prepared meals improve the quality of their diet compared to participants who receive only physical activity education and coaching.
Trial Details
NCT Number NCT07126587
Lead Sponsor University of North Carolina, Chapel Hill
Collaborators: Westat, National Heart, Lung, and Blood Institute (NHLBI)
Conditions Obesity (Disorder), Diabetes Type 2, Heart Disease, Hypertension, Cancer, High Cholesterol
Enrollment 44 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov